RTP drug developer advances Alzheimer’s treatment – Triangle Business Journal

June 27, 2015 by  
Filed under Alzheimers News

Sponsored By

Triangle Business Journal
RTP drug developer advances Alzheimer's treatment
Triangle Business Journal
A small Research Triangle Park drug developer founded by a former GlaxoSmithKline executive thinks it has a way to fight Alzheimer's, a disease that has for years frustrated drug developers big and small. The company – T3D Therapeutics, Inc., founded
Triangle startup to test experimental treatment on Alzheimer's patientsNews & Observer

all 2 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!